| Combination therapy with anti-PD-1, anti-TIM-3, and focal radiation results in regression of murine gliomas JE Kim, MA Patel, A Mangraviti, ES Kim, D Theodros, E Velarde, A Liu, ... Clinical Cancer Research 23 (1), 124-136, 2017 | 426 | 2017 |
| Anti–PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM D Mathios, JE Kim, A Mangraviti, J Phallen, CK Park, CM Jackson, ... Science translational medicine 8 (370), 370ra180-370ra180, 2016 | 276 | 2016 |
| Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance AM Martin, TR Nirschl, CJ Nirschl, BJ Francica, CM Kochel, ... Prostate cancer and prostatic diseases 18 (4), 325-332, 2015 | 206 | 2015 |
| Expression of LAG‐3 and efficacy of combination treatment with anti‐LAG‐3 and anti‐PD‐1 monoclonal antibodies in glioblastoma S Harris‐Bookman, D Mathios, AM Martin, Y Xia, E Kim, H Xu, Z Belcaid, ... International journal of cancer 143 (12), 3201-3208, 2018 | 128 | 2018 |
| Management of pediatric and adult patients with medulloblastoma AM Martin, E Raabe, C Eberhart, KJ Cohen Current treatment options in oncology 15, 581-594, 2014 | 114 | 2014 |
| The Cdk-activating kinase Cak1p promotes meiotic S phase through Ime2p K Schindler, KR Benjamin, A Martin, A Boglioli, I Herskowitz, E Winter Molecular and cellular biology 23 (23), 8718-8728, 2003 | 60 | 2003 |
| PD-L1 expression in medulloblastoma: An evaluation by subgroup AM Martin, CJ Nirschl, MJ Polanczyk, WR Bell, TR Nirschl, ... Oncotarget 9 (27), 19177, 2018 | 56 | 2018 |
| The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis B Gran, N Tabibzadeh, A Martin, ES Ventura, JH Ware, GX Zhang, JL Parr, ... Multiple Sclerosis Journal 12 (6), 688-697, 2006 | 49 | 2006 |
| Targeting DDX3 in medulloblastoma using the small molecule inhibitor RK-33 S Tantravedi, F Vesuna, PT Winnard Jr, A Martin, M Lim, CG Eberhart, ... Translational oncology 12 (1), 96-105, 2019 | 41 | 2019 |
| Parent perspectives on oncology team communication regarding neurocognitive impacts of cancer therapy and school reentry K Ruble, J Paré‐Blagoev, S Cooper, A Martin, LA Jacobson Pediatric Blood & Cancer 66 (1), e27427, 2019 | 39 | 2019 |
| Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization T Barberi, A Martin, R Suresh, DJ Barakat, S Harris-Bookman, CG Drake, ... Cancer Immunology, Immunotherapy 67, 1491-1503, 2018 | 29 | 2018 |
| Postchemotherapy immunization practices for non-HSCT pediatric oncology patients L Zhang, AM Martin, K Ruble Journal of Pediatric Hematology/Oncology 41 (4), 289-293, 2019 | 10 | 2019 |
